Spyre Therapeutics (SYRE) Change in Account Payables (2015 - 2026)
Spyre Therapeutics posted quarterly Change in Account Payables of $36000.0 for Q1 2026, down 98.81% year-on-year from $3.0 million in Q1 2025, and up 100.49% on a QoQ basis from -$7.4 million in Q4 2025.
Spyre Therapeutics (SYRE) has 12 years of Change in Account Payables data on file, last reported at $36000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables fell 98.81% year-over-year to $36000.0; the trailing twelve-month figure through Mar 2026 stood at -$3.6 million (down 713.38% YoY), and the FY2025 full-year result was -$589000.0, down 156.09% from the prior year.
- Change in Account Payables for Q1 2026 stood at $36000.0, up from -$7.4 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $7.4 million in Q3 2025 and bottomed at -$7.4 million in Q4 2025.
- The 5-year median for Change in Account Payables is $125000.0 (2024), against an average of -$37666.7.
- The widest annual swing landed in 2022, when Change in Account Payables jumped 503.58%; it then sank 2976.0% in 2025.
- A 5-year view of Change in Account Payables shows it stood at $1.4 million in 2022, then surged by 72.56% to $2.3 million in 2023, then plunged by 292.8% to -$4.5 million in 2024, then slumped by 64.07% to -$7.4 million in 2025, then soared by 100.49% to $36000.0 in 2026.
- The last three Change in Account Payables figures came in at $36000.0 (Q1 2026), -$7.4 million (Q4 2025), and $7.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -3.26 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 35.60 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Spyre Therapeutics | 5.55 Bn | 5.55 Bn | - | 36,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 36,000.00 |
| Mar 31, 2026 | 36,000.00 |
| Dec 31, 2025 | -7.38 Mn |
| Dec 31, 2025 | -7.38 Mn |
| Sep 30, 2025 | 7.36 Mn |
| Sep 30, 2025 | 7.36 Mn |
| Jun 30, 2025 | -3.60 Mn |
| Jun 30, 2025 | -3.60 Mn |
| Mar 31, 2025 | 3.02 Mn |
| Mar 31, 2025 | 3.02 Mn |
| Dec 31, 2024 | -4.50 Mn |
| Dec 31, 2024 | -4.50 Mn |
| Sep 30, 2024 | 1.93 Mn |
| Sep 30, 2024 | 1.93 Mn |
| Jun 30, 2024 | 125,000.00 |
| Jun 30, 2024 | 125,000.00 |
| Mar 31, 2024 | 2.21 Mn |
| Mar 31, 2024 | 2.21 Mn |
| Dec 31, 2023 | 2.33 Mn |
| Dec 31, 2023 | 2.33 Mn |
| Sep 30, 2023 | -4.16 Mn |
| Sep 30, 2023 | -4.16 Mn |
| Jun 30, 2023 | 2.05 Mn |
| Jun 30, 2023 | 2.05 Mn |
| Sep 30, 2022 | 1.35 Mn |
| Sep 30, 2022 | 1.35 Mn |
| Jun 30, 2022 | -1.01 Mn |
| Jun 30, 2022 | -1.01 Mn |
| Mar 31, 2022 | -338,000.00 |
| Mar 31, 2022 | -338,000.00 |
| Dec 31, 2021 | 390,000.00 |
| Dec 31, 2021 | 390,000.00 |
| Sep 30, 2021 | -335,000.00 |
| Sep 30, 2021 | -335,000.00 |
| Jun 30, 2021 | 321,000.00 |
| Jun 30, 2021 | 321,000.00 |
| Mar 31, 2021 | -376,000.00 |
| Mar 31, 2021 | -376,000.00 |
| Dec 31, 2020 | -5,000.00 |
| Dec 31, 2020 | -5,000.00 |
| Sep 30, 2020 | -1.86 Mn |
| Sep 30, 2020 | -1.86 Mn |
| Jun 30, 2020 | 1.06 Mn |
| Jun 30, 2020 | 1.06 Mn |
| Mar 31, 2020 | 262,000.00 |
| Mar 31, 2020 | 262,000.00 |
| Dec 31, 2019 | 749,000.00 |
| Dec 31, 2019 | 749,000.00 |
| Sep 30, 2019 | -307,000.00 |
| Sep 30, 2019 | -307,000.00 |
| Jun 30, 2019 | -148,000.00 |
| Jun 30, 2019 | -148,000.00 |
| Mar 31, 2019 | 2.29 Mn |
| Mar 31, 2019 | 2.29 Mn |
| Dec 31, 2018 | -488,000.00 |
| Dec 31, 2018 | -488,000.00 |
| Sep 30, 2018 | 148,000.00 |
| Sep 30, 2018 | 148,000.00 |
| Jun 30, 2018 | 183,000.00 |
| Jun 30, 2018 | 183,000.00 |
| Mar 31, 2018 | 396,000.00 |
| Mar 31, 2018 | 396,000.00 |
| Dec 31, 2017 | -283,000.00 |
| Dec 31, 2017 | -283,000.00 |
| Sep 30, 2017 | 107,000.00 |
| Sep 30, 2017 | 107,000.00 |
| Jun 30, 2017 | 245,000.00 |
| Jun 30, 2017 | 245,000.00 |
| Mar 31, 2017 | 95,000.00 |
| Mar 31, 2017 | 95,000.00 |
| Dec 31, 2016 | -355,000.00 |
| Dec 31, 2016 | -355,000.00 |
| Sep 30, 2016 | 175,000.00 |
| Sep 30, 2016 | 175,000.00 |
| Jun 30, 2016 | -89,000.00 |
| Jun 30, 2016 | -89,000.00 |
| Mar 31, 2016 | 261,000.00 |
| Mar 31, 2016 | 261,000.00 |
| Dec 31, 2015 | -386,000.00 |
| Dec 31, 2015 | -386,000.00 |
| Sep 30, 2015 | -227,000.00 |
| Sep 30, 2015 | -227,000.00 |
| Jun 30, 2015 | 462,000.00 |
| Jun 30, 2015 | 462,000.00 |
| Mar 31, 2015 | -18,000.00 |
| Mar 31, 2015 | -18,000.00 |